Not applicableStudy completedNCT01056354What this trial is testingRespiratory Virus Outpatient Study (FLU 002 Plus)Who this might be right forInfluenza and Other Novel Respiratory Viruses University of Minnesota 11,719
Post-approval studies (Phase 4)Study completedNCT01022905What this trial is testingVaccine Responses to Influenza A H1N1/09 Immunization in High-risk PatientsWho this might be right forHIV InfectionRheumatic DiseaseCancer+2 more University Hospital, Geneva 1,141
Post-approval studies (Phase 4)Study completedNCT02143882What this trial is testingA Phase III/IV Open-label Study of the Immunogenicity and Safety of a Single Dose of a Live Attenuated Influenza Vaccine (LAIV) (FluenzTM) for Each of Three Successive Years in Children naïve to, or in Previous Receipt of the AS03B Adjuvanted H1N1 (2009) Influenza Vaccine (Pandemrix ™).Who this might be right forLive Attenuated Influenza Vaccine Public Health England 300
Large-scale testing (Phase 3)Study completedNCT00996307What this trial is testingPivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 MonthsWho this might be right forInfluenza Novartis Vaccines 654
Large-scale testing (Phase 3)Study completedNCT01000207What this trial is testingSingle-blind, Dose-ranging Study of Novel Swine Influenza Virus Vaccine in Japanese Pediatric SubjectsWho this might be right forSwine-Origin Influenza A H1N1 Virus Novartis Vaccines 123
Large-scale testing (Phase 3)Study completedNCT01001325What this trial is testingDoes Seasonal Influenza Vaccination Affect the Incidence of pH1N1 Influenza?Who this might be right forInfluenza Mount Sinai Hospital, Canada 468
Not applicableEnded earlyNCT04810949What this trial is testingVitamine D3 Supplementation in Patients With Serum Values +/- 20ng/mlWho this might be right forCovid19Influenza AInfluenza B+1 more Hospital Clinica Nova 41
Not applicableStudy completedNCT01203527What this trial is testingThe Pharmacology of Tamiflu in PregnancyWho this might be right forH1N1 Influenza Treatment During Pregnancy Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 63
Early research (Phase 1)Study completedNCT02014870What this trial is testingSafety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy VolunteersWho this might be right forInfluenza A Immune Targeting Systems Ltd 29
Testing effectiveness (Phase 2)Study completedNCT00985088What this trial is testingSafety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and OlderWho this might be right forInfluenza GlaxoSmithKline 1,343
Not applicableUnknownNCT01277380What this trial is testingAnalysis of the Results From Influenza Rapid Test A Positive and H1N1 Real Time RT-PCRWho this might be right forH1N1 Influenza Virus Taipei Medical University WanFang Hospital 100
Large-scale testing (Phase 3)Study completedNCT06087640What this trial is testingA Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults ≥65 Years of AgeWho this might be right forInfluenza, Human Seqirus 38,769
Not applicableStudy completedNCT01056185What this trial is testingRespiratory Virus Hospitalization Study (FLU 003 Plus)Who this might be right forInfluenzaNovel Respiratory Virus-1 Middle Eastern Respiratory Syndrome Coronavirus (MERS-CoV)Novel Respiratory Virus-2 Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) University of Minnesota 1,000
Large-scale testing (Phase 3)Study completedNCT00971425What this trial is testingEvaluation of the Immune Response and the Safety of a Pandemic Influenza Candidate Vaccine (H1N1)Who this might be right forInfluenza GlaxoSmithKline 145
Testing effectiveness (Phase 2)Study completedNCT00956046What this trial is testingSwine-origin A/H1N1 Influenza Vaccines in Healthy Europeans Children Aged 6 to 35 MonthsWho this might be right forInfluenzaSwine-origin A/H1N1 Influenza Sanofi Pasteur, a Sanofi Company 401
Testing effectiveness (Phase 2)Study completedNCT00976469What this trial is testingA/H1N1 Immunogenicity and Safety in Infants, Children and AdolescentsWho this might be right forInfluenzaPandemic Influenza Alachua Government Services, Inc. 400
Post-approval studies (Phase 4)Study completedNCT01000831What this trial is testingRapid Evaluation of Pandemic H1N1 Influenza Vaccines in Young ChildrenWho this might be right forInfluenza University of British Columbia 167
Early research (Phase 1)Study completedNCT01111968What this trial is testingEvaluation of Pandemic Influenza A (H1N1)Candidate VaccinesWho this might be right forInfluenza Butantan Institute 266
Early research (Phase 1)Study completedNCT01855945What this trial is testingSafety and Immunogenicity of Three Dosage Levels of Swine Influenza Vaccine in Children Ages 3 to <9 Years, Adolescents 9 to <18 Years, Adults 18 to <65 Years and Elderly 65 Years and Older.Who this might be right forProphylaxis of A/H3N2v Influenza Novartis Vaccines 627
Testing effectiveness (Phase 2)Study completedNCT00956202What this trial is testingInactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 YearsWho this might be right forInfluenzaSwine-origin A/H1N1 Influenza Sanofi Pasteur, a Sanofi Company 303